Kymera Therapeutics Inc (KYMR) Insider Trading
- $107,377,856.56
- $154,074,084.12
- March 11, 2026
- Nello Mainolfi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 11, 2026 | COO | 25,758 | $83.30 | Sell | $2,145,641.40 | |
| March 4, 2026 | Insider | 4,895 | $85.30 | Sell | $417,543.50 | |
| March 4, 2026 | COO | 3,919 | $85.30 | Sell | $334,290.70 | |
| March 4, 2026 | CFO | 4,895 | $85.30 | Sell | $417,543.50 | |
| March 2, 2026 | CFO | 7,576 | $88.93 | Sell | $673,733.68 | |
| March 2, 2026 | COO | 2,039 | $88.93 | Sell | $181,328.27 | |
| March 2, 2026 | Director | 81,866 | $90.13 | Sell | $7,378,582.58 | |
| March 2, 2026 | Insider | 5,613 | $88.93 | Sell | $499,164.09 | |
| Feb. 25, 2026 | CEO | 30,000 | $90.26 | Sell | $2,707,800.00 | |
| Sept. 17, 2025 | CFO | 79,220 | $50.00 | Sell | $3,961,000.00 | |
| Sept. 16, 2025 | CEO | 30,000 | $49.00 | Sell | $1,470,000.00 | |
| June 30, 2025 | Director | 655,500 | $44.00 | Buy | $28,842,000.00 | |
| June 30, 2025 | Director | 317,167 | $44.00 | Buy | $13,955,348.00 | |
| June 3, 2025 | Director | 6,349 | $49.00 | Sell | $311,101.00 | |
| June 3, 2025 | CEO | 30,000 | $49.00 | Sell | $1,470,000.00 | |
| June 3, 2025 | Director | 12,000 | $46.10 | Sell | $553,200.00 | |
| March 3, 2025 | Insider | 2,241 | $30.45 | Sell | $68,238.45 | |
| March 3, 2025 | COO | 1,383 | $30.45 | Sell | $42,112.35 | |
| March 3, 2025 | CFO | 7,035 | $30.45 | Sell | $214,215.75 | |
| Jan. 6, 2025 | Insider | 3,129 | $41.75 | Sell | $130,635.75 | |
| Sept. 17, 2024 | Director | 13,500 | $48.28 | Sell | $651,780.00 | |
| Aug. 26, 2024 | Director | 5,000 | $49.10 | Sell | $245,500.00 | |
| July 16, 2024 | Insider | 23,145 | $45.81 | Sell | $1,060,272.45 | |
| July 9, 2024 | Director | 453,960 | $38.21 | Sell | $17,345,811.60 | |
| June 12, 2024 | Director | 16,740 | $35.45 | Sell | $593,433.00 | |
| June 7, 2024 | Director | 8,500 | $32.99 | Sell | $280,415.00 | |
| March 15, 2024 | Director | 71,764 | $40.46 | Sell | $2,903,571.44 | |
| March 13, 2024 | Major Shareholder | 115,090 | $42.23 | Sell | $4,860,250.70 | |
| March 13, 2024 | Director | 139,255 | $42.23 | Sell | $5,880,738.65 | |
| March 11, 2024 | Director | 51,184 | $42.85 | Sell | $2,193,234.40 | |
| March 11, 2024 | Major Shareholder | 42,302 | $42.85 | Sell | $1,812,640.70 | |
| March 4, 2024 | CFO | 3,934 | $41.86 | Sell | $164,677.24 | |
| Feb. 21, 2024 | Director | 4,385 | $39.05 | Sell | $171,234.25 | |
| Feb. 9, 2024 | Insider | 46,137 | $35.50 | Sell | $1,637,863.50 | |
| Jan. 23, 2024 | Director | 10,000 | $30.05 | Sell | $300,500.00 | |
| Jan. 4, 2024 | Insider | 3,295 | $22.58 | Sell | $74,401.10 | |
| Nov. 2, 2023 | Director | 216,406 | $11.64 | Buy | $2,518,965.84 | |
| March 2, 2023 | CFO | 1,370 | $31.00 | Sell | $42,470.00 | |
| Jan. 11, 2023 | Major Shareholder | 21,683 | $29.96 | Sell | $649,622.68 | |
| Jan. 11, 2023 | Director | 22,110 | $29.89 | Buy | $660,867.90 | |
| Dec. 14, 2022 | Director | 378,966 | $31.37 | Sell | $11,888,163.42 | |
| Dec. 14, 2022 | Major Shareholder | 296,077 | $31.37 | Sell | $9,287,935.49 | |
| Nov. 2, 2022 | Major Shareholder | 96,581 | $30.02 | Sell | $2,899,361.62 | |
| Nov. 2, 2022 | Director | 123,619 | $30.02 | Sell | $3,711,042.38 | |
| Oct. 31, 2022 | Major Shareholder | 94,239 | $30.23 | Sell | $2,848,844.97 | |
| Oct. 31, 2022 | Director | 120,622 | $30.23 | Sell | $3,646,403.06 | |
| Oct. 28, 2022 | Major Shareholder | 71,135 | $30.00 | Sell | $2,134,050.00 | |
| Oct. 28, 2022 | Director | 91,050 | $30.00 | Sell | $2,731,500.00 | |
| Aug. 22, 2022 | Director | 545,525 | $26.00 | Buy | $14,183,650.00 | |
| May 26, 2022 | Director | 224,057 | $14.21 | Buy | $3,183,849.97 |
Insiders are both buying and selling Kymera Therapeutics Inc stock.
The insider traders at Kymera Therapeutics Inc are: Nello Mainolfi, Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Jared Gollob, Venture Fund X L.P. Atlas, Jeremy G Chadwick, Jeffrey W. Albers, Ellen Chiniara, Richard Chesworth, Pamela Esposito, Bros. Advisors Lp Baker, Elena Ridloff, Joanna Horobin, and Bruce N. Jacobs
The most active insider trader at Kymera Therapeutics Inc is Nello Mainolfi with 22 trades.
Bruce Booth has sold the most Kymera Therapeutics Inc stock with a total value of $93,379,451.11.
Bvf Partners L P/Il has bought the most Kymera Therapeutics Inc stock with a total value of $92,491,204.56.
The most recent insider trade for Kymera Therapeutics Inc was on March 11, 2026.
The single biggest insider buy for Kymera Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $28,842,000.00 on June 30, 2025.
The single biggest insider sell for Kymera Therapeutics Inc was from Bruce Booth with a total value of $17,345,811.60 on July 9, 2024.
